A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial.

Autor: McKetin R; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia. r.mcketin@unsw.edu.au., Degan TJ; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia., Saunders L; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia., Nguyen L; Burnet Institute, Melbourne, Australia., Dore G; Kirby Institute, University of New South Wales, Sydney, Australia., Shoptaw S; Department of Family Medicine, David Geffen School of Medicine, Los Angeles, USA., Farrell M; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia., Degenhardt L; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia., Kelly PJ; School of Psychology, Faculty of Arts, Social Sciences and Humanities, University of Wollongong, Wollongong, Australia., Turner A; IMPACT, School of Medicine, Deakin University, Geelong, Australia., Clare PJ; Prevention Research Collaboration, The University of Sydney, Sydney, Australia., Dean OM; IMPACT, School of Medicine, Deakin University, Geelong, Australia., Arunogiri S; Alfred Psychiatry Research Centre (MAPrc), Central Clinical School, Monash University, Melbourne, Australia., Colledge-Frisby S; Burnet Institute, Melbourne, Australia.; National Drug Research Institute, Curtin University, Perth, Australia., Koeijers J; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia., Goodman-Meza D; Center for HIV Identification, Prevention, and Treatment Services, Los Angeles, USA., Sinclair B; Illawarra Drug and Alcohol Service, Illawarra Shoalhaven Local Health District, NSW Health, Wollongong, Australia., Reid D; Illawarra Drug and Alcohol Service, Illawarra Shoalhaven Local Health District, NSW Health, Wollongong, Australia., Hill H; Drug and Alcohol Services, Barwon Health, Geelong, Australia., Hayllar J; Biala City Community Health Centre, Metro North Health, Brisbane, Australia., Christmass M; Next Step Community Alcohol and Drug Service East Perth, East Perth, Australia., Cordaro F; Illawarra Drug and Alcohol Service, Illawarra Shoalhaven Local Health District, NSW Health, Wollongong, Australia., Lundin R; Drug and Alcohol Services, Barwon Health, Geelong, Australia., Liaw W; Drug and Alcohol Services of South Australia, Adelaide, Australia., Liu D; Drug and Alcohol Services of South Australia, Adelaide, Australia., Holyoak E; Alcohol, Tobacco & Other Drug Services, Townsville, Australia., Wu BT; Alcohol, Tobacco & Other Drug Services, Townsville, Australia., Keygan J; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia., Kontogiannis A; School of Psychology, Faculty of Arts, Social Sciences and Humanities, University of Wollongong, Wollongong, Australia., Palmer L; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia., Morrison C; IMPACT, School of Medicine, Deakin University, Geelong, Australia., Wrobel A; IMPACT, School of Medicine, Deakin University, Geelong, Australia., Hyland B; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia., Byrne M; Kirby Institute, University of New South Wales, Sydney, Australia., Russell S; IMPACT, School of Medicine, Deakin University, Geelong, Australia.; Grampians Health, Ballarat, Australia., Zahra E; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia., Berk M; IMPACT, School of Medicine, Deakin University, Geelong, Australia.; Drug and Alcohol Services, Barwon Health, Geelong, Australia.; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia.

Publikováno v: Trials [Trials] 2024 Jun 22; Vol. 25 (1), pp. 408. Date of Electronic Publication: 2024 Jun 22.

Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study.

Autor: Conway A; The Kirby Institute, UNSW, Sydney, Australia. a.conway@unsw.edu.au.; Centre for Social Research in Health, UNSW, Sydney, Australia. a.conway@unsw.edu.au., Marshall AD; The Kirby Institute, UNSW, Sydney, Australia.; Centre for Social Research in Health, UNSW, Sydney, Australia., Crawford S; Harm Reduction Victoria, Melbourne, Australia., Hayllar J; Alcohol and Drug Service, Metro North Mental Health, Metro North Hospital and Health Service, Brisbane, Australia., Grebely J; The Kirby Institute, UNSW, Sydney, Australia., Treloar C; Centre for Social Research in Health, UNSW, Sydney, Australia.

Publikováno v: Implementation science : IS [Implement Sci] 2023 Jun 09; Vol. 18 (1), pp. 22. Date of Electronic Publication: 2023 Jun 09.

"You'll come in and dose even in a global pandemic": A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic.

Autor: Conway A; The Kirby Institute, UNSW, Sydney, Australia; Centre for Social Research in Health, UNSW, Sydney, Australia. Electronic address: a.conway@unsw.edu.au., Treloar C; Centre for Social Research in Health, UNSW, Sydney, Australia., Crawford S; Harm Reduction Victoria, Melbourne, Australia., Degenhardt L; National Drug and Alcohol Research Centre, UNSW, Sydney, Australia., Dore GJ; The Kirby Institute, UNSW, Sydney, Australia., Farrell M; National Drug and Alcohol Research Centre, UNSW, Sydney, Australia., Hayllar J; Alcohol and Drug Service, Metro North Mental Health, Metro North Hospital and Health Service, Brisbane, Queensland, Australia., Grebely J; The Kirby Institute, UNSW, Sydney, Australia., Marshall AD; The Kirby Institute, UNSW, Sydney, Australia; Centre for Social Research in Health, UNSW, Sydney, Australia.

Publikováno v: The International journal on drug policy [Int J Drug Policy] 2023 Apr; Vol. 114, pp. 103998. Date of Electronic Publication: 2023 Mar 06.

Kamini, a little recognised source of illicit opioid: A case series of 12 patients.

Autor: Khan T; Addiction Service, Metro South Health, Logan, Australia., Ariyawansa P; Alcohol and Other Drug Service, Gold Coast Health, Gold Coast, Australia., Quinn J; Alcohol and Drug Service, West Moreton Health, Ipswich, Australia., Hayllar J; Alcohol and Drug Service, Metro North Health, Brisbane, Australia.

Publikováno v: Drug and alcohol review [Drug Alcohol Rev] 2022 Sep; Vol. 41 (6), pp. 1404-1407. Date of Electronic Publication: 2022 May 12.

A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study.

Autor: Conway A; The Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia.; Centre for Social Research in Health, UNSW Sydney, Sydney, NSW 2052, Australia., Valerio H; The Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia., Alavi M; The Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia., Silk D; The Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia., Treloar C; Centre for Social Research in Health, UNSW Sydney, Sydney, NSW 2052, Australia., Hajarizadeh B; The Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia., Marshall AD; The Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia.; Centre for Social Research in Health, UNSW Sydney, Sydney, NSW 2052, Australia., Martinello M; The Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia., Milat A; Centre for Epidemiology and Evidence, NSW Health, Sydney, NSW 2065, Australia., Dunlop A; Hepatitis NSW, Surry Hills, NSW 2010, Australia.; Drug and Alcohol Clinical Services, Hunter New England Local Health District, Newcastle, NSW 2300, Australia., Murray C; Population Health Strategy & Performance, NSW Health, Sydney, NSW 2065, Australia., Prain B; Population Health Strategy & Performance, NSW Health, Sydney, NSW 2065, Australia., Henderson C; NSW Users and AIDS Association, Surry Hills, NSW 2010, Australia., Amin J; Department of Health Systems and Populations, Macquarie University, Sydney, NSW 2109, Australia., Read P; Kirketon Road Centre, Sydney, NSW 2010, Australia., Marks P; The Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia., Degenhardt L; National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, NSW 2052, Australia., Hayllar J; Alcohol and Drug Service, Metro North Mental Health, Metro North Hospital and Health Service, Brisbane, QLD 4029, Australia., Reid D; Drug and Alcohol Service, Illawarra Shoalhaven Local Health District, Wollongong, NSW 2500, Australia., Gorton C; Cairns Sexual Health Service, Cairns, QLD 4870, Australia., Lam T; Drug Health, Western Sydney Local Health District, Sydney, NSW 2145, Australia., Christmass M; Next Step Community Alcohol and Drug Service, Perth, WA 6004, Australia.; National Drug Research Institute, Curtin University, Perth, WA 6102, Australia., Wade A; Mid North Coast Liver Clinic, Mid North Coast Local Health District, Coffs Harbour, NSW 2450, Australia.; Drug and Alcohol Services, Mid North Coast Local Health District, Coffs Harbour, NSW 2450, Australia., Montebello M; North Sydney Local Health District, Sydney, NSW 2077, Australia., Dore GJ; The Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia., Grebely J; The Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia.

Publikováno v: Viruses [Viruses] 2022 Jul 16; Vol. 14 (7). Date of Electronic Publication: 2022 Jul 16.